Skip to Content
Warren, Jayapal Announce Three Drug Manufacturers Pulled Sham Patents after Warnings, Urge FDA to Continue Fight Against Big Pharma Companies’ Patent Abuse
Lawmakers Probed Big Pharma’s Sham Patent Claims after FTC Warnings in December 2023; Are Now Sharing Responses with…
Issues:
Health Care,
Science, Technology, & Antitrust
Centers for Medicare and Medicaid Services Has Authority to Curb Billions in Overpayments to Private Medicare Advantage Insurers
Washington, D.C. – U.S. Representative Pramila Jayapal (D-Wash.) and U.S. Senator Elizabeth Warren (D-Mass.), a member of the Senate Finance Committee, sent…
Issues:
Health Care
Many Major Pharmacy Chains Provide Prescription Records to Law Enforcement Agencies Without A Court Order; Birth Control, Mental Health And Other Sensitive, Personal Conditions Can Be Revealed
Washington, D.C. – Rep. Pramila Jayapal, D-Wash., with Senate Finance Committee Chair Ron…
Issues:
Civil Rights,
Health Care
Washington, DC – Representatives Pramila Jayapal (WA-07), Barbara Lee (CA-12), and Joaquin Castro (TX-20) joined with Senators Cory Booker (D-NJ), Dick Durbin (D-IL), and Mazie Hirono (D-HI) to call on the Department of Health and Human Services (HHS) to finalize their…
Issues:
Health Care,
Immigration
“UnitedHealth Group’s proposed … acquisition of … Amedisys is the latest example of massive health care conglomerates using anticompetitive mergers to increase their market dominance, reducing competition, hurting patients, and increasing health care costs.”
“Blocking anticompetitive deals and rejecting the…
Issues:
Health Care,
Science, Technology, & Antitrust
FTC To Hold Open Meeting To Consider Key Policy Statement on Improper Patent Listings
Big Pharma Exploits FDA’s “Orange Book” to Prevent the Entry of Lower-Cost Generics and Block Competition
Text of Letter (PDF)
Washington, D.C. – U.S. Representative Pramila…
Issues:
Health Care,
Science, Technology, & Antitrust
